Roanoke Heart Institute

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia2 trials
• Amyloidosis1 trial
• Coronary artery disease1 trial
• Peripheral artery disease1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 34 trials

Status

• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Eidos Therapeutics, a BridgeBio company1 trial
• Novo Nordisk A/S1 trial

Running trials

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

  NCT04988386· Phase 3· Eidos Therapeutics, a BridgeBio company· Source

Closed trials

• Completed

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· Phase 3· Novo Nordisk A/S· Source